Fig. 2From: H19 overexpression promotes leukemogenesis and predicts unfavorable prognosis in acute myeloid leukemiaThe impact of H19 expression on survival in AML. a Overall survival (OS) among whole-cohort AML patients. b OS among non-APL-AML patients. c OS among cytogenetically normal AML (CN-AML) patients. d Leukemia-free survival (LFS) among whole-cohort AML patients. e LFS among non-APL-AML patients. f LFS among CN-AML patientsBack to article page